<DOC>
	<DOCNO>NCT01644370</DOCNO>
	<brief_summary>To explore allergen-specific effector regulatory T cell response HIV-infected child HAART initiation</brief_summary>
	<brief_title>Children With HIV Asthma ( CHIVAS )</brief_title>
	<detailed_description>Recently , US investigator observe HIV-infected ( HIV+ ) child highly active antiretroviral therapy ( HAART ) much great cumulative incidence asthma.Regulatory T cell may mitigate pathogenicity asthma suppression Th2 responses . Since asthma predominantly TH2 mediate condition , propose new onset asthma HAART HIV- infect child may secondary dysregulated immune reconstitution . The restoration CD4+ T cell-mediated immunity HIV+ patient treat HAART may lead airway inflammation , narrow , hyperresponsiveness , possibly remodel . The increased incidence asthma HIV-infected child treat HAART likely secondary multiple factor may include hypersensitivity certain aeroallergens , dysregulation effector regulatory T cell response , well imbalance TH1 vs. TH2 cytokine . Therefore study identify immunopathogenesis increase airway hyperresponsiveness HIV-positive patient .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Children age 218 year 2 . Parent sign inform consent child sign assent form 3 . Children start highly active antiretroviral therapy ( HAART ) due clinical indication switch HAART due treatment failure within 45 day screen visit 1 . Pregnancy 2 . History chronic lung disease include lymphoid interstitial pneumonitis ( LIP ) , bronchopulmonary dysplasia ( BPD ) . 3 . Active opportunistic infection i.e . pulmonary tuberculosis , PCP , pneumonia 4 . Conditions limit ability subject comprehend questionnaire ( i.e . mental retardation ) .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>HIV-infected child</keyword>
	<keyword>T cell response</keyword>
	<keyword>asthma</keyword>
</DOC>